NCT03212625View on ClinicalTrials.gov

The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction

PHASE4CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

January 28, 2016

Primary Completion Date

September 20, 2018

Study Completion Date

September 20, 2018

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Urea Cream 20%

Sorafenib 400mg (twice daily), Spread urea cream (urea 20%)

DRUG

Placebos

Sorafenib 400mg (twice daily), Spread placebo cream (urea 0%)

Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Hanmi Pharmaceutical Company Limited

INDUSTRY

lead

Korea University Guro Hospital

OTHER

NCT03212625 - The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction | Biotech Hunter | Biotech Hunter